Rompharm Company decreased its stake in Sopharma from c.18% to 9.41%, according to a regulatory filing. Sopharma informed that Rompharm Company has sold almost half of its stake in the Company and currently has 9.41% as of Dec 8th, 2017.
Monbat AD, pursuant to Art. 92a, para. 1 of the Public Offering of Securities Act (POSA), informs the investors about the beginning of a public offering of up to 30 000 (thirty thousand) dematerialized, interest-bearing, convertible, freely transferable and unsecured bonds with an issue and nominal value of one bond in the amount of EUR 1 000 (one thousand)
bg
